Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 208

The DOI matches its Crossref record.

Metabolism of Ginsenoside Rc by Human Intestinal Bacteria and Its Related Antiallergic Activity.

Open access
Bae, Eun-Ah, Choo, Min-Kyung, Park, Eun-Kyung, Park, Sun-Young, Shin, Ho-Young, Kim, Dong-Hyun·2002·Biological and Pharmaceutical Bulletin

Abstract

When ginsenoside R(c) was anaerobically incubated with human fecal microflora, all specimens metabolized ginsenoside R(c) to compound K and protopanaxadiol. The main metabolite was compound K. Among the bacteria isolated from human fecal microflora, most bacteria, such as Bacteroides sp., Eubacterium sp., and Bifidobacterium sp. potently transformed ginsenoside R(c) to compound K. Bifidobacterium K-103 and Eubacterium A-44 transformed it to compound K via ginsenoside R(d) and Bacteroides HJ-15 and Bifidobacterium K-506 metabolized to compound K via ginsenoside Mb, which was isolated as a new metabolite (M.W. 940[+Na]). Among ginsenoside R(c) and its metabolites, compound K exhibited the most potent antiallergic activity on the IgE-induced RBL cell line as well as potent cytotoxic activity against tumor cell lines.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1248/bpb.25.743

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 208

Metadata

Authors
Bae, E.-A., Choo, M.-K., Park, E.-K., Park, S.-Y., Shin, H.-Y., & Kim, D.-H.
Venue
Biological and Pharmaceutical Bulletin
Published
2002
Volume
25
Issue
6
Pages
743-747
ISSN
  • 0918-6158 (ISSN-L)
  • 1347-5215
OpenAlex
W1990119075
Cited by
208
References
0
FWCI
1.62
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metabolism of Ginsenoside Rc by Human Intestinal Bacteria and Its Related Antiallergic Activity. https://app.cochat.ai/papers/10.1248/bpb.25.743
The paper
Bae, E.-A., Choo, M.-K., Park, E.-K., Park, S.-Y., Shin, H.-Y., & Kim, D.-H. (2002). Metabolism of Ginsenoside Rc by Human Intestinal Bacteria and Its Related Antiallergic Activity. Biological and Pharmaceutical Bulletin. https://doi.org/10.1248/bpb.25.743

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.